These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10846713)

  • 21. Androgen deprivation treatment of sexual behavior.
    Houts FW; Taller I; Tucker DE; Berlin FS
    Adv Psychosom Med; 2011; 31():149-163. PubMed ID: 22005210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of mental retardation with paraphilia treated with depot leuprorelin.
    Park WS; Kim KM; Jung YW; Lim MH
    J Korean Med Sci; 2014 Sep; 29(9):1320-4. PubMed ID: 25246754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Urolithiasis in the Long-Term GnRH Agonist Treatment of Patients with Paraphilia: 3 Case Studies].
    Mayrhofer G; Wegner D; Voß T
    Aktuelle Urol; 2016 Dec; 47(6):487-490. PubMed ID: 27701680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cyproteronacetat treatment of sexual offenders.
    Berner W; Brownstone G; Sluga W
    Neurosci Biobehav Rev; 1983; 7(3):441-3. PubMed ID: 6230546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sex hormones, neurotransmitters, and psychopharmacological treatments in men with paraphilic disorders.
    Saleh FM; Berlin FS
    J Child Sex Abus; 2003; 12(3-4):233-53. PubMed ID: 15308453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protocols for the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia.
    Reilly DR; Delva NJ; Hudson RW
    Can J Psychiatry; 2000 Aug; 45(6):559-63. PubMed ID: 10986575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Issues to consider in the assessment and treatment of paraphilic patients.
    Saleh FM
    J Clin Psychiatry; 2005 Jun; 66(6):802-3; author reply 803. PubMed ID: 15960581
    [No Abstract]   [Full Text] [Related]  

  • 28. Erectile function and nocturnal penile tumescence in patients with prostate cancer undergoing luteinizing hormone-releasing hormone agonist therapy.
    Marumo K; Baba S; Murai M
    Int J Urol; 1999 Jan; 6(1):19-23. PubMed ID: 10221860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LH-RH agonists modulate amygdala response to visual sexual stimulation: a single case fMRI study in pedophilia.
    Habermeyer B; Händel N; Lemoine P; Klarhöfer M; Seifritz E; Dittmann V; Graf M
    Neurocase; 2012; 18(6):489-95. PubMed ID: 22136615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A placebo-controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality.
    Cooper AJ
    Compr Psychiatry; 1981; 22(5):458-65. PubMed ID: 6230209
    [No Abstract]   [Full Text] [Related]  

  • 31. Medroxyprogesterone acetate antiandrogen treatment of hypersexuality in a pedophiliac sex offender.
    Cordoba OA; Chapel JL
    Am J Psychiatry; 1983 Aug; 140(8):1036-9. PubMed ID: 6223535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sadistic homosexual pedophilia: treatment with cyproterone acetate: a single case study.
    Bradford JM; Pawlak A
    Can J Psychiatry; 1987 Feb; 32(1):22-30. PubMed ID: 2949821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Use of Leuprolide Acetate in the Management of High-Risk Sex Offenders.
    Gallo A; Abracen J; Looman J; Jeglic E; Dickey R
    Sex Abuse; 2019 Dec; 31(8):930-951. PubMed ID: 30047834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological treatments for paraphilic patients and sexual offenders.
    Briken P; Kafka MP
    Curr Opin Psychiatry; 2007 Nov; 20(6):609-13. PubMed ID: 17921764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sadistic homosexual pedophilia treatment with cyproterone acetate.
    Cooper AJ; Baxter D; Wong W; Losztyn S
    Can J Psychiatry; 1987 Nov; 32(8):738-40. PubMed ID: 2961433
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacological management of inappropriate sexual behaviours: a review of its evidence, rationale and scope in relation to men with intellectual disabilities.
    Sajith SG; Morgan C; Clarke D
    J Intellect Disabil Res; 2008 Dec; 52(12):1078-90. PubMed ID: 18557968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of sex offenders with medroxyprogesterone acetate.
    Gagné P
    Am J Psychiatry; 1981 May; 138(5):644-6. PubMed ID: 6453536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of sex offenders with antiandrogenic medication: conceptualization, review of treatment modalities, and preliminary findings.
    Berlin FS; Meinecke CF
    Am J Psychiatry; 1981 May; 138(5):601-7. PubMed ID: 6453535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy of sexual offenders.
    Richer M; Crismon ML
    Ann Pharmacother; 1993 Mar; 27(3):316-20. PubMed ID: 8453171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of combined androgen blockade with an LHRH agonist and flutamide in one severe case of male exhibitionism.
    Rousseau L; Couture M; Dupont A; Labrie F; Couture N
    Can J Psychiatry; 1990 May; 35(4):338-41. PubMed ID: 2189544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.